Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

BACKGROUND: The insulin-like growth factor 1 (IGF-1) pathway is involved in cell growth and proliferation and is associated with tumorigenesis and therapy resistance. This study aims to elucidate whether variation in the IGF-1 pathway is predictive for pathologic response in early HER2 negative brea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: de Groot, Stefanie, Charehbili, Ayoub, van Laarhoven, Hanneke W. M., Mooyaart, Antien L., Dekker-Ensink, N. Geeske, van de Ven, Saskia, Janssen, Laura G. M., Swen, Jesse J., Smit, Vincent T. H. B. M., Heijns, Joan B., Kessels, Lonneke W., van der Straaten, Tahar, Böhringer, Stefan, Gelderblom, Hans, van der Hoeven, Jacobus J. M., Guchelaar, Henk-Jan, Pijl, Hanno, Kroep, Judith R.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4702399/
https://ncbi.nlm.nih.gov/pubmed/26738606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0663-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados